Flindr Therapeutics
Flindr – first in class small molecule targeted therapeutics
Oss, Netherlands · $21.4M raised
- Headquarters
- Oss
- Employees
- 1–10
- Website
- flindrtx.com
- Total Funding
- $21.4M
- Last Round
- $21.4M Series AApr 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Restores impaired immune response to cancer
Summary
Flindr Therapeutics is a Biotech company based in Oss, Netherlands. It has raised $21.4M in total across 1 round, most recently a $21.4M Series A round in Apr 2024. Investors include V-Bio Ventures and Johnson & Johnson Innovation.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/flindr-therapeutics"><img src="https://indexed.vc/api/badge/company/flindr-therapeutics" alt="Flindr Therapeutics on Indexed.vc" width="260" height="76" /></a>